Zobrazeno 1 - 10
of 170
pro vyhledávání: '"HAROLD M. MAURER"'
Autor:
R. Beverly Raney, Harold M. Maurer, James R. Anderson, Richard J. Andrassy, Sarah S. Donaldson, Stephen J. Qualman, Moody D. Wharam, Eugene S. Wiener, William M. Crist
Publikováno v:
Sarcoma, Vol 5, Iss 1, Pp 9-15 (2001)
Purpose. To enumerate lessons from studying 4292 patients with rhabdomyosarcoma (RMS) in the Intergroup Rhabdomyosarcoma Study Group (IRSG, 1972–1997).
Externí odkaz:
https://doaj.org/article/049afee05d604017b907d7d8cfa236c9
Publikováno v:
Sarcomas of Bone and Soft Tissues in Children and Adolescents ISBN: 9783030511586
The first large multi-institutional trial in children and adolescents less than 21 years of age with rhabdomyosarcoma (RMS) and undifferentiated soft-tissue sarcoma (UDS) was planned by members of the Children’s Cancer Study Group A (CCSGA) in Nort
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::113f338ea31c7b834d0cb22fdc975b4f
https://doi.org/10.1007/978-3-030-51160-9_4
https://doi.org/10.1007/978-3-030-51160-9_4
Autor:
William M. Crist, James R. Anderson, Moody D. Wharam, R. Beverly Raney, Carola A.S. Arndt, Harold M. Maurer, Ken Brown, Julie A. Stoner, Richard J. Andrassy, William H. Meyer, Stephen J. Qualman, Andrea Hayes-Jordan, Eugene S. Wiener
Publikováno v:
Journal of Pediatric Surgery. 45:2160-2168
Purposes The aims of the study were to compare results of clinical/radiographic studies before second-look procedures (SLP) with SLP specimens from patients with gross residual sarcoma at diagnosis and to relate tumor viability to outcome. Patients S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::659fac87661a579f63e629b1843f3fe6
https://doi.org/10.1016/j.jpedsurg.2010.07.021
https://doi.org/10.1016/j.jpedsurg.2010.07.021
Autor:
Frederick B. Ruymann, Seymour Grufferman, Simona Ognjanovic, Erik B. Erhardt, Harold M. Maurer
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 18:1271-1276
The association between antenatal diagnostic X-ray exposure and risk of rhabdomyosarcoma in children was assessed in a national case-control study of 319 rhabdomyosarcoma cases and 319 matched controls. Data were collected by telephone interviews of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de5c7b0f8f5b583730341385300ff6ae
https://doi.org/10.1158/1055-9965.epi-08-0775
https://doi.org/10.1158/1055-9965.epi-08-0775
Autor:
Moody D. Wharam, James R. Anderson, Carola A.S. Arndt, Eugene S. Wiener, Harold M. Maurer, William H. Meyer, Beverly Raney, Stephen J. Qualman, Willam Crist
Publikováno v:
Pediatric Blood & Cancer. 51:339-343
Purpose To describe clinical and pathologic characteristics and outcome of patients with renal sarcomas.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::52f3c8a8fc134b196139f8cf0e27e780
https://doi.org/10.1002/pbc.21639
https://doi.org/10.1002/pbc.21639
Autor:
Jeff M. Michalski, Stephen J. Qualman, Lynn M. Smith, Alberto S. Pappo, Eugene S. Wiener, Richard J. Andrassy, Suzanne L. Wolden, Eric Sandler, Lisa A. Teot, Moody D. Wharam, John C. Breneman, K. Scott Baker, David O. Walterhouse, Leslie L. Robison, Holcome E. Grier, Julie Moore, Peter J. Houghton, William H. Meyer, Paul H B Sorenson, Richard B. Womer, Ken M. Brown, W. Archie Bleyer, Stephen X. Skapek, Thom L. Lobe, Kathleen Nicol, Frederic G. Barr, Sheri L. Spunt, Philip P. Breitfeld, David M. Parham, Carola A.S. Arndt, Julia A. Bridge, Harold M. Maurer, Douglas S. Hawkins, Sarah S. Donaldson, R. Beverly Raney, Michael P. Link, Charles N. Paidas, Van H. Savell
Publikováno v:
Pediatric and Developmental Pathology. 10:89-97
Morphologically, the distinction between undifferentiated embryonal sarcoma of the liver (UESL) and biliary tract rhabdomyosarcoma (RMS) can be uncertain because of some shared pathologic similarities. Patients with UESL have been consistently but er
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::992ea57d296bdda47610d8dd788db317
https://doi.org/10.2350/06-03-0068.1
https://doi.org/10.2350/06-03-0068.1
Publikováno v:
Cancer. 52:44-50
Four hundred and twenty-three children with newly-diagnosed soft-tissue sarcoma were treated on the Intergroup Rhabdomyosarcoma Study I from November 1972 through December 1976. After institution of therapy, 341/423 (80.6%) achieved a complete respon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::22ce9aa2d0d3c81f308c4f21697c2bd9
https://doi.org/10.1002/1097-0142(19830701)52:1<44::aid-cncr2820520110>3.0.co
https://doi.org/10.1002/1097-0142(19830701)52:1<44::aid-cncr2820520110>3.0.co
Autor:
Harold M. Maurer, Alberto S. Pappo, Jane L. Meza, Sarah S. Donaldson, Moody D. Wharam, William M. Crist, Stephen J. Qualman, Eugene S. Wiener
Publikováno v:
Journal of Clinical Oncology. 21:638-645
Purpose: The characteristics and clinical outcomes of children and adolescents with localized nonorbital, nonparameningeal head and neck rhabdomyosarcoma (RMS) treated on national protocols from the Intergroup Rhabdomyosarcoma Group are reported. Pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78a17a362434a5abb79f7f98fbe3a999
https://doi.org/10.1200/jco.2003.01.032
https://doi.org/10.1200/jco.2003.01.032
Autor:
Lynn M. Smith, Alberto S. Pappo, Charles N. Paidas, John C. Breneman, Eugene S. Wiener, R. Beverly Raney, Michael P. Link, James R. Anderson, Lisa A. Teot, Stephen J. Qualman, Holcombe E. Grier, Harold M. Maurer, William M. Crist, Sarah S. Donaldson
Publikováno v:
Journal of Clinical Oncology. 19:4058-4064
PURPOSE: To identify which patients with rhabdomyosarcoma and microscopic residual disease (group II) are likely to not respond to therapy. PATIENTS AND METHODS: Six hundred ninety-five patients with group II tumors received chemotherapy and 90% rece
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a4dd6bc6e3ecc441fbcb37f960d908d
https://doi.org/10.1200/jco.2001.19.20.4058
https://doi.org/10.1200/jco.2001.19.20.4058
Autor:
Joan L. Leeson, Thom E. Lobe, Eugene S. Wiener, Timothy J. Triche, Philip P. Breitfeld, Richard J. Andrassy, Douglas S. Hawkins, Sarah S. Donaldson, R. Beverly Raney, Michael P. Link, Moody D. Wharam, William H. Meyer, W. Archie Bleyer, Carola A.S. Arndt, Frederick B. Ruymann, Lisa Teot, John C. Breneman, Eric Sandler, David M. Parham, Lisa A. Teot, Sharon E. Murphy, William M. Crist, Teresa J. Vietti, Frederic G. Barr, K. Scott Baker, David O. Walterhouse, Lynn M. Smith, Leslie L. Robison, Suzanne L. Wolden, Alberto S. Pappo, Jeff M. Michalski, Peter J. Houghton, Julia A. Bridge, James R. Anderson, Charles N. Paidas, Stephen J. Qualman, Harold M. Maurer, Holcombe E. Grier, Elizabeth Lyden, Ken M. Brown, Richard B. Womer, Poul H. Sorensen
Publikováno v:
Journal of Pediatric Hematology/Oncology. 23:225-233
Purpose: This study was designed to estimate the partial and complete response rates (CR and PR) of two novel drug pairs (vincristine and melphalan vs. ifosfamide and etoposide) and to improve overall survival of previously untreated patients with me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0d88c09b6a9ee6017550bcf7d4b20dab
https://doi.org/10.1097/00043426-200105000-00010
https://doi.org/10.1097/00043426-200105000-00010